News
News

Lyndra News

Lyndra’s LYNX™ drug delivery platform has progressed far faster than industry standards. In 2022, Lyndra is planning to bring oral weekly risperidone (LYN-005) into pivotal trials and to advance several new assets into the clinic.

Filter

{content}
Showing: All